Please login to the form below

Not currently logged in
Email:
Password:

EADV congress

This page shows the latest EADV congress news and features for those working in and with pharma, biotech and healthcare.

Novartis' secukinumab has 'consistent' activity in psoriasis

Novartis' secukinumab has 'consistent' activity in psoriasis

The data - which was presented at the European Association of Dermatology and Venereology (EADV) Congress in Amsterdam this week - reinforces earlier studies suggesting that secukinumab was more effective in treating psoriasis ... Novartis reported

Latest news

  • Trial success for Novartis' psoriasis drug

    Trial success for Novartis' psoriasis drug. Novartis has presented data at the European Academy of Dermatology and Venereology Congress that demonstrates investigational psoriasis treatment AIN457 is effective in up to 81 ... Novartis has presented data

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics